Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer, Part 1: Technical Considerations

SIMPLE SUMMARY: High-grade serous ovarian cancer (HGSOC) is the most frequent and lethal form of ovarian cancer and is associated with homologous recombination deficiency (HRD) in 50% of cases. This specific alteration is associated with sensitivity to PARP inhibitors (PARPis). Despite vast prognost...

Descripción completa

Detalles Bibliográficos
Autores principales: Quesada, Stanislas, Fabbro, Michel, Solassol, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909526/
https://www.ncbi.nlm.nih.gov/pubmed/35267439
http://dx.doi.org/10.3390/cancers14051132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909526/
https://www.ncbi.nlm.nih.gov/pubmed/35267439
http://dx.doi.org/10.3390/cancers14051132

Ejemplares similares